FDA Approved: QVAR REDIHALER — Original Application (Teva Respiratory, LLC)

View source ↗

Summary

FDA approved the original application for QVAR REDIHALER (beclomethasone dipropionate HFA) by Teva Respiratory, LLC. It is approved for the treatment of asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QVAR REDIHALER (Beclomethasone dipropionate HFA)

Snippet

ORIG AP for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)